In transgenic mice that produce the chronic deposition of amyloid-β, called APP/PS1 mice, those lacking in NLRP3 and caspase-1 have been described as a link between the NLRP3 inflammasome pathway and AD. The gene discussed is CASP1; the disease is Alzheimer disease.